# INBP (Integrated Biopharma Inc.) - SEC EDGAR Financial Statements

> Integrated Biopharma Inc. reported $41.10M in revenue and a net loss of $3.66M for the trailing twelve months ended September 30, 2026 (down 21.9% year over year), with a -0.8% gross margin and a -9.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/INBP
- Markdown: https://convexityos.com/fundamentals/INBP.md
- SEC CIK: 0001016504
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001016504&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $41.10M | -21.9% YoY |
| Operating Income | TTM | -$3.83M | -9.3% margin |
| Net Income | TTM | -$3.66M | -8.9% net margin |
| Diluted EPS | TTM | -$0.12 | Split-adjusted |
| Free Cash Flow | TTM | -$1.58M | -3.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $3.12M | Total debt: $2.78M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $43.87M | $54.35M | $50.32M | $50.67M | $56.25M | $63.56M | $52.77M | $49.98M | $43.71M | $46.95M |
| Cost of Revenue | $43.07M | $48.79M | $46.43M | $46.61M | $49.69M | $54.08M | $46.04M | $43.76M | $38.72M | $40.29M |
| **Gross Profit** | $800K | $5.56M | $3.88M | $4.06M | $6.55M | $9.48M | $6.73M | $6.22M | $4.99M | $6.67M |
| Selling, General & Admin | $3.50M | $3.54M | $3.63M | $3.94M | $3.81M | $3.70M | $3.47M | $3.52M | $3.29M | $3.48M |
| **Operating Income** | -$2.71M | $2.02M | $251K | $120K | $2.75M | $5.78M | $3.26M | $2.70M | $1.69M | $3.19M |
| **EBITDA** | -$2.41M | $2.34M | $558K | $471K | $3.08M | $6.12M | $3.57M | $3.02M | $2.04M | $3.58M |
| Interest Expense | $12K | $46K | $52K | $52K | $128K | $256K | $397K | $630K | $926K | $911K |
| Income Before Tax | -$2.56M | $2.06M | $268K | $100K | $2.60M | $7.25M | $3.09M | $2.04M | $1.00M | $1.86M |
| Income Tax Expense | $279K | $1.25M | $156K | $134K | -$1.24M | -$766K | -$1.02M | $354K | $326K | -$490K |
| **Net Income** | -$2.84M | $808K | $112K | -$34K | $3.84M | $8.01M | $4.11M | $1.69M | $679K | $2.35M |
| Basic EPS | -$0.09 | $0.03 | $0.00 | $0.00 | $0.13 | $0.27 | $0.14 | $0.06 | $0.03 | $0.11 |
| **Diluted EPS** | -$0.09 | $0.03 | $0.00 | $0.00 | $0.12 | $0.25 | $0.13 | $0.06 | $0.02 | $0.10 |
| Basic Shares Outstanding | 31.1M | 30.3M | 30.1M | 29.9M | 29.8M | 29.7M | 29.6M | 28.9M | 21.1M | 21.1M |
| Diluted Shares Outstanding | 31.1M | 31.2M | 30.9M | 29.9M | 32.3M | 32.1M | 31.2M | 29.6M | 30.3M | 30.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.91M | $9.80M | $10.11M | $11.28M | $12.69M | $14.18M | $13.95M | $12.61M |
| Cost of Revenue | $10.03M | $9.77M | $10.38M | $11.25M | $11.67M | $12.71M | $12.40M | $11.44M |
| **Gross Profit** | -$112K | $28K | -$276K | $29K | $1.02M | $1.47M | $1.55M | $1.17M |
| Selling, General & Admin | $849K | $897K | $809K | $943K | $856K | $880K | $812K | $969K |
| **Operating Income** | -$961K | -$869K | -$1.08M | -$914K | $163K | $589K | $739K | $202K |
| **EBITDA** | -$894K | -$799K | -$1.02M | -$836K | $240K | $660K | $818K | $285K |
| Interest Expense | -- | -- | -$39K | -$40K | -$33K | -$9.0K | -$5.0K | -$11K |
| Income Before Tax | -$923K | -$850K | -$1.03M | -$874K | $196K | $595K | $778K | $185K |
| Income Tax Expense | -$232K | $516K | -$198K | -$112K | $73K | $773K | $167K | $69K |
| **Net Income** | -$691K | -$1.37M | -$837K | -$762K | $123K | -$178K | $611K | $116K |
| Basic EPS | -$0.02 | -- | -$0.03 | -$0.03 | $0.00 | -- | $0.02 | $0.00 |
| **Diluted EPS** | -$0.02 | -- | -$0.03 | -$0.03 | $0.00 | -- | $0.02 | $0.01 |
| Basic Shares Outstanding | 31.1M | -- | 31.1M | 31.1M | 31.1M | -- | 30.3M | 30.2M |
| Diluted Shares Outstanding | 31.1M | -- | 31.1M | 31.1M | 31.4M | -- | 31.5M | 31.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.47M | $3.62M | $1.68M | $1.32M | $331K | $210K | $402K | $475K | $228K | $132K |
| **Cash & Short-Term Investments** | $4.47M | $3.62M | $1.68M | $1.32M | $331K | $210K | $402K | $475K | $228K | $132K |
| Accounts Receivable, Net | $3.33M | $5.43M | $4.67M | $4.51M | $4.89M | $5.78M | $5.51M | $4.44M | $3.80M | $4.02M |
| Inventory | $9.14M | $9.36M | $11.24M | $10.26M | $11.05M | $11.70M | $11.70M | $8.82M | $7.74M | $7.64M |
| Other Current Assets | $432K | $356K | $286K | $284K | $352K | $317K | $451K | $346K | $493K | $754K |
| **Total Current Assets** | $17.38M | $18.76M | $17.88M | $16.37M | $16.63M | $18.00M | $16.46M | $14.08M | $12.26M | $12.55M |
| Property, Plant & Equipment, Net | $1.75M | $1.72M | $1.80M | $1.65M | $1.91M | $1.74M | $1.74M | $1.78M | $1.78M | $1.60M |
| **Total Non-Current Assets** | $7.96M | $6.14M | $8.33M | $9.84M | $8.62M | $7.44M | $6.48M | $5.71M | $2.31M | $2.65M |
| **Total Assets** | $25.34M | $24.90M | $26.21M | $26.21M | $25.25M | $25.44M | $22.94M | $19.79M | $14.57M | $15.20M |
| Accounts Payable | $3.20M | $2.27M | $2.51M | $2.27M | $3.21M | $3.50M | $4.36M | $3.85M | $4.18M | $4.18M |
| Short-Term Debt | -- | -- | -- | $42K | $32K | $1.46M | $2.82M | $1.05M | $773K | $1.12M |
| **Total Current Liabilities** | $5.80M | $4.25M | $6.12M | $4.83M | $5.26M | $9.24M | $13.10M | $12.35M | $16.18M | $11.15M |
| Long-Term Debt | -- | -- | -- | $7.0K | $53K | $0 | $1.44M | $2.72M | $3.62M | $4.25M |
| **Total Non-Current Liabilities** | $1.87M | $336K | $846K | $1.74M | $1.41M | $1.87M | $3.78M | $5.54M | $3.62M | $9.97M |
| **Total Liabilities** | $7.67M | $4.58M | $6.97M | $6.57M | $6.67M | $11.11M | $16.88M | $17.90M | $19.80M | $21.12M |
| **Total Debt (incl. Leases)** | $3.08M | $1.01M | $1.80M | $2.72M | $1.95M | $3.83M | $7.16M | $7.33M | $4.40M | $5.36M |
| Common Stock | $62K | $62K | $60K | $60K | $60K | $60K | $59K | $59K | $42K | $42K |
| Retained Earnings | -$34.26M | -$31.42M | -$32.23M | -$32.34M | -$32.30M | -$36.14M | -$44.16M | -$48.26M | -$49.95M | -$50.63M |
| **Total Stockholders' Equity** | $17.67M | $20.32M | $19.24M | $18.86M | $18.57M | $14.33M | $6.07M | $1.89M | -$5.24M | -$5.93M |
| Total Equity | $17.67M | $20.32M | $19.24M | $18.86M | $18.57M | $14.33M | $6.07M | $1.89M | -$5.24M | -$5.93M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.12M | $4.47M | $5.83M | $5.31M | $4.73M | $3.62M | $2.96M | $2.46M |
| **Cash & Short-Term Investments** | $3.12M | $4.47M | $5.83M | $5.31M | $4.73M | $3.62M | $2.96M | $2.46M |
| Accounts Receivable, Net | $3.72M | $3.33M | $3.65M | $3.59M | $3.98M | $5.43M | $5.08M | $4.23M |
| Inventory | $8.54M | $9.14M | $8.12M | $8.36M | $10.47M | $9.36M | $10.08M | $11.07M |
| Other Current Assets | $595K | $432K | $374K | $550K | $440K | $356K | $428K | $398K |
| **Total Current Assets** | $15.98M | $17.38M | $17.97M | $17.82M | $19.62M | $18.76M | $18.55M | $18.15M |
| Property, Plant & Equipment, Net | $1.81M | $1.75M | $1.70M | $1.76M | $1.82M | $1.72M | $1.81M | $1.77M |
| **Total Non-Current Assets** | $8.05M | $7.96M | $8.70M | $5.73M | $5.92M | $6.14M | $7.11M | $7.51M |
| **Total Assets** | $24.03M | $25.34M | $26.67M | $23.55M | $25.54M | $24.90M | $25.66M | $25.66M |
| Accounts Payable | $2.82M | $3.20M | $2.96M | $2.14M | $2.80M | $2.27M | $2.50M | $2.81M |
| **Total Current Liabilities** | $5.45M | $5.80M | $5.53M | $3.54M | $4.76M | $4.25M | $4.98M | $5.58M |
| **Total Non-Current Liabilities** | $1.56M | $1.87M | $2.16M | $237K | $287K | $336K | $292K | $359K |
| **Total Liabilities** | $7.01M | $7.67M | $7.69M | $3.78M | $5.05M | $4.58M | $5.27M | $5.93M |
| **Total Debt (incl. Leases)** | $2.78M | $3.08M | $3.09M | $504K | $761K | $1.01M | $1.14M | $1.32M |
| Common Stock | $62K | $62K | $62K | $61K | $62K | $62K | $61K | $61K |
| Retained Earnings | -$34.95M | -$34.26M | -$32.90M | -$32.06M | -$31.30M | -$31.42M | -$31.24M | -$31.85M |
| **Total Stockholders' Equity** | $17.02M | $17.67M | $18.98M | $19.77M | $20.49M | $20.32M | $20.38M | $20K |
| Total Equity | $17.02M | $17.67M | $18.98M | $19.77M | $20.49M | $20.32M | $20.38M | $20K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.84M | $808K | $112K | -$34K | $3.84M | $8.01M | $4.11M | $1.69M | $679K | $2.35M |
| Depreciation & Amortization | $293K | $318K | $307K | $351K | $336K | $337K | $312K | $321K | $348K | $393K |
| Stock-Based Compensation | $192K | $185K | $252K | $320K | $369K | $231K | $59K | $144K | $14K | $49K |
| Change in Receivables | $2.10M | -$781K | -$120K | $374K | $875K | -$294K | -$1.08M | -$593K | $182K | -$884K |
| Change in Inventory | $220K | $1.88M | -$983K | $794K | $640K | -$1.59M | -$1.28M | -$1.08M | -$96K | $111K |
| Change in Payables | $925K | -$211K | $244K | -$921K | -$218K | -$937K | $487K | -$329K | $7.0K | -$1.29M |
| **Operating Cash Flow** | $1.24M | $2.06M | $943K | $1.23M | $4.09M | $3.05M | $1.34M | $328K | $1.17M | $397K |
| Capital Expenditure | -$346K | -$191K | -$553K | -$116K | -$486K | -$295K | -$214K | -$414K | -$247K | -$327K |
| **Free Cash Flow** | $895K | $1.87M | $390K | $1.12M | $3.60M | $2.75M | $1.12M | -$86K | $921K | $70K |
| Sales & Maturities of Investments | -- | -- | $0 | $4.0K | $0 | $96K | $101K | -- | -- | -- |
| **Investing Cash Flow** | -$340K | -$205K | -$553K | -$111K | -$465K | -$199K | -$110K | -$422K | -$242K | -$327K |
| **Financing Cash Flow** | -$45K | $78K | -$29K | -$136K | -$3.50M | -$3.04M | -$1.30M | $341K | -$830K | -$333K |
| **Net Change in Cash** | $856K | $1.94M | $361K | $985K | $121K | -$192K | -$73K | $247K | $96K | -$263K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$691K | -$1.37M | -$837K | -$762K | $123K | -$178K | $611K | $116K |
| Depreciation & Amortization | $67K | $70K | $68K | $78K | $77K | $71K | $79K | $83K |
| Stock-Based Compensation | $39K | $51K | $50K | $42K | $49K | $44K | $45K | $43K |
| Change in Receivables | -$386K | $321K | -$63K | $391K | $1.45M | -$369K | -$852K | $157K |
| Change in Inventory | $597K | -$1.02M | $244K | $2.11M | -$1.11M | $715K | $989K | $158K |
| Change in Payables | -$378K | $227K | $821K | -$656K | $533K | -$238K | -$271K | $45K |
| **Operating Cash Flow** | -$1.22M | -$1.19M | $517K | $617K | $1.30M | $591K | $616K | $201K |
| Capital Expenditure | -$124K | -$149K | $0 | -$24K | -$173K | $10K | -$116K | -$29K |
| **Free Cash Flow** | -$1.34M | -$1.34M | $517K | $593K | $1.13M | $601K | $500K | $172K |
| **Investing Cash Flow** | -$124K | -$149K | $6.0K | -$24K | -$173K | -$4.0K | -$116K | -$29K |
| **Financing Cash Flow** | -$12K | -$12K | -$11K | -$11K | -$11K | $67K | $0 | $18K |
| **Net Change in Cash** | -$1.35M | -$1.35M | $512K | $582K | $1.12M | $654K | $500K | $190K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 1.8% | 10.2% | 7.7% | 8.0% | 11.6% | 14.9% | 12.7% | 12.4% | 11.4% | 14.2% |
| **Operating Margin** | -6.2% | 3.7% | 0.5% | 0.2% | 4.9% | 9.1% | 6.2% | 5.4% | 3.9% | 6.8% |
| **Net Profit Margin** | -6.5% | 1.5% | 0.2% | -0.1% | 6.8% | 12.6% | 7.8% | 3.4% | 1.6% | 5.0% |
| Return on Equity (ROE) | -16.1% | 4.0% | 0.6% | -0.2% | 20.7% | 55.9% | 67.7% | 89.2% | -- | -- |
| Return on Assets (ROA) | -11.2% | 3.2% | 0.4% | -0.1% | 15.2% | 31.5% | 17.9% | 8.5% | 4.7% | 15.4% |
| Current Ratio | 3.00x | 4.42x | 2.92x | 3.39x | 3.16x | 1.95x | 1.26x | 1.14x | 0.76x | 1.13x |
| Quick Ratio | 1.42x | 2.21x | 1.08x | 1.27x | 1.06x | 0.68x | 0.36x | 0.43x | 0.28x | 0.44x |
| Debt to Equity | 0.17x | 0.05x | 0.09x | 0.14x | 0.11x | 0.27x | 1.18x | 3.87x | -- | -- |
| **Revenue Growth (YoY)** | -19.3% | +8.0% | -0.7% | -9.9% | -11.5% | +20.4% | +5.6% | +14.3% | -6.9% | +11.2% |
| Gross Profit Growth (YoY) | -85.6% | +43.2% | -4.4% | -38.0% | -30.9% | +40.9% | +8.1% | +24.7% | -25.2% | +21.1% |
| Operating Income Growth (YoY) | -233.9% | +704.8% | +109.2% | -95.6% | -52.5% | +77.5% | +20.5% | +59.6% | -46.8% | +50.8% |
| **Net Income Growth (YoY)** | -451.7% | +621.4% | -- | -100.9% | -52.1% | +95.1% | +143.4% | +148.6% | -71.1% | +144.9% |
| EPS Growth (YoY) | -400.0% | -- | -- | -100.0% | -51.9% | +92.9% | +133.3% | +100.0% | -72.7% | +120.0% |
| Operating Cash Flow Growth (YoY) | -39.9% | +119.0% | -23.5% | -69.9% | +34.1% | +127.8% | +308.2% | -71.9% | +194.2% | -- |
| Free Cash Flow Growth (YoY) | -52.2% | +380.5% | -65.1% | -69.0% | +30.9% | +144.9% | -- | -109.3% | +1215.7% | -- |
| 5Y Revenue / Share Growth | -34.0% | +0.5% | -3.1% | -18.2% | -15.2% | +7.0% | +0.5% | +8.1% | +29.7% | +27.6% |
| 10Y Revenue / Share Growth | -29.4% | +1.0% | +4.7% | +6.1% | +8.2% | +9.4% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -133.9% | -80.8% | -93.6% | -103.5% | +15.8% | +494.4% | +298.9% | +839.0% | +628.2% | -- |
| 10Y Net Income / Share Growth | -301.6% | -23.4% | -40.1% | -125.7% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -0.8% | 1.8% | 4.6% | 7.8% | 9.8% | 10.2% | 10.2% | 9.7% |
| **Operating Margin** | -9.3% | -6.2% | -2.6% | 1.1% | 3.2% | 3.7% | 3.5% | 2.8% |
| **Net Profit Margin** | -8.9% | -6.5% | -3.4% | -0.4% | 1.3% | 1.5% | 2.4% | 1.8% |
| Return on Equity (ROE) | -21.5% | -16.1% | -8.7% | -1.0% | 3.3% | 4.0% | 6.2% | 4704.2% |
| Return on Assets (ROA) | -15.2% | -11.2% | -6.2% | -0.9% | 2.6% | 3.2% | 4.9% | 3.6% |
| Current Ratio | 2.93x | 3.00x | 3.25x | 5.03x | 4.12x | 4.42x | 3.72x | 3.26x |
| Quick Ratio | 1.36x | 1.42x | 1.78x | 2.67x | 1.92x | 2.21x | 1.70x | 1.27x |
| Debt to Equity | 0.16x | 0.17x | 0.16x | 0.03x | 0.04x | 0.05x | 0.06x | 67.07x |
| **Revenue Growth (YoY)** | -21.9% | -30.9% | -27.5% | -10.6% | -6.8% | +11.2% | +6.1% | +9.6% |
| Gross Profit Growth (YoY) | -111.0% | -98.1% | -117.8% | -97.5% | -25.7% | +14.4% | +24.3% | +125.2% |
| Operating Income Growth (YoY) | -689.6% | -247.5% | -246.8% | -552.5% | -66.7% | +46.5% | +108.2% | -- |
| **Net Income Growth (YoY)** | -661.8% | -- | -237.0% | -756.9% | -52.5% | -166.4% | +114.4% | -- |
| EPS Growth (YoY) | -- | -- | -250.0% | -- | -100.0% | -- | +100.0% | -- |
| Operating Cash Flow Growth (YoY) | -193.7% | -302.0% | -16.1% | +207.0% | +98.0% | -- | -62.5% | -- |
| Free Cash Flow Growth (YoY) | -219.1% | -323.5% | +3.4% | +244.8% | +87.7% | -- | -61.5% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
